PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshypokalemia
MeSH D007008 - hypokalemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014883:Water-electrolyte imbalance
$
Success rate
D007008: 
Hypokalemia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaHydrochlorothiazide, Amiloride Amiloride Hydrochlorothiazide  1988-04-17   
Spironolactone Spironolactone  1982-01-01   
Hydrochlorothiazide, Spironolactone Spironolactone W/ Hydrochlorothiazide  1982-05-24   
MylanSpironolactone Spironolactone  2001-08-20   
Hydrochlorothiazide, Spironolactone Spironolactone Hydrochlorothiazide  1982-01-01   
Hydrochlorothiazide, Triamterene Triamterene Hydrochlorothiazide  1996-06-07   
GSKHydrochlorothiazide, Triamterene Dyazide  1982-01-01   
SandozHydrochlorothiazide, Triamterene Triamterene Hydrochlorothiazide  1988-06-17   
NovartisHydrochlorothiazide, Triamterene Triamterene Hydrochlorothiazide  1997-09-09   
Merck & CoHydrochlorothiazide, Amiloride Moduretic  1982-01-01   
PfizerHydrochlorothiazide, Spironolactone Aldactazide  1982-12-30   
Spironolactone Aldactone  1982-12-30   
Hydrochlorothiazide, Spironolactone Spironolactone W/ Hydrochlorothiazide  1983-02-22   
Aurobindo PharmaHydrochlorothiazide, Triamterene Maxzide  1984-10-22   
Spironolactone Spironolactone  2014-03-06   
Barr PharmaceuticalsHydrochlorothiazide, Amiloride Amiloride Hydrochlorothiazide  1988-05-10   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Pfizer
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use